← All Celularity INC filings

Celularity INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
CELU
Celularity INC
DEFA14A: Celularity Inc. Files Definitive Proxy Statement
Celularity Inc. has filed a definitive proxy statement with the SEC under Schedule 14A.
NASDAQ
CELU
Celularity INC
DEF: Celularity Sets 2025 Annual Meeting, Seeks Director Re-election, Equity Plan Boost
Celularity Inc. announces its 2025 Annual Meeting of Stockholders to elect Class I directors, ratify its independent auditor, and approve an increase of 3.5 million shares for its 2021 Equity Incentive Plan.
NASDAQ
CELU
Celularity INC
DEF 14A: Celularity Inc. Announces 2024 Annual Meeting of Stockholders
Celularity Inc. will hold its 2024 Annual Meeting of Stockholders on December 19, 2024, to elect a Class III director and ratify the appointment of its independent auditor.